SynergyMed is entering a pivotal phase: our second set of clinical trials on dogs is about to begin in partnership with a prestigious U.S. research institution. Our Founder and CEO is currently in the Boston area, overseeing device setup and trial preparations on-site.

This is a strategic moment to invest—or to increase your investment—in a company making meaningful progress toward real-world impact.

We’d be thrilled to have you with us as we take this next major step forward.